儿童重度哮喘:评估、分类与管理的再认识
儿童哮喘多数经低剂量吸入糖皮质激素(ICS)可控制,但对高剂量ICS及其他控制药物抵抗者属问题性重度哮喘;仅按处方治疗级别定义重度哮喘过于狭窄,需详细评估确认诊断、共病,并由护士主导分类为困难哮喘或严重治疗抵抗性哮喘。本文重新审视这两类的交互与管理,指出二分法可能需重新考虑,并用支气管镜与肌注类固醇判断类固醇抵抗性哮喘,因成人定义不适用于约半数患儿。
要点
- 儿童重度哮喘需先确认诊断、评估共病,再行护士主导的详细评估分类。
- 仅按处方治疗级别定义重度哮喘过于狭窄,需多维度评估。
- 儿童重度哮喘与成人不同,不能不加批判地照搬成人方案。
核心结论
- 儿童重度哮喘与成人重度哮喘差异显著,评估与管理方法不可盲目从成人外推至儿童。
- 仅基于处方治疗级别的重度哮喘定义过于狭窄,需对患儿进行详细评估。
研究设计与样本
- 本文为综述性再评估,基于英国国家哮喘死亡审查的启示,讨论儿童重度哮喘的评估与分类。
- 采用支气管镜与肌内注射类固醇判断类固醇抵抗性哮喘,因成人定义不适用于约半数患儿。
主要发现
- 即使在高剂量ICS和其他控制器治疗下仍 apparent 抵抗的患儿,属问题性重度哮喘。
- 护士主导的评估可将患儿常规分类为困难哮喘或严重治疗抵抗性哮喘。
- 嗜酸性重度哮喘中可缺乏T-helper 2(TH2)细胞因子,固有上皮细胞因子IL-33可能起重要作用。
- 诱导痰中可检测谱系阴性固有淋巴细胞,且上皮内中性粒细胞与更好的哮喘结局相关。
关键数值与推荐
- 多数儿童哮喘在规律正确使用低剂量ICS时可轻易控制。
- 对高剂量ICS及其他控制器治疗 apparent 抵抗的患儿,需详细评估确认诊断并评估共病。
临床怎么用
- 对疑似重度哮喘患儿,应先确认诊断、评估共病,再行护士主导的详细评估以区分困难哮喘与严重治疗抵抗性哮喘。
- 考虑使用支气管镜与肌内注射类固醇判断类固醇抵抗性哮喘,尤其当成人定义不适用时。
局限性
- 本文为综述性再评估,未报告原始研究的具体样本量、阈值或统计值。
- 文中指出二分法分类可能需要重新考虑,但未给出新的分类标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Most children with asthma have their disease easily controlled if low-dose inhaled corticosteroids (ICSs) are regularly and correctly administered. If a child presents with asthma which is apparently resistant to therapy with high-dose ICS and other controllers, then they have problematic severe asthma. However, in light of the UK National Review of Asthma Deaths, definitions of severe asthma based solely on the levels of prescribed treatment are too narrow. A detailed assessment of all such children should be performed. First, the diagnosis of asthma should be confirmed, then co-morbidities assessed. Next, a nurse-led assessment further characterizes the problem, conventionally categorizing the child as either having difficult asthma or severe therapy-resistant asthma. Here, we reassess in particular the interactions between, and management of, these two categories, highlighting that this dichotomous classification may need reconsideration. We use bronchoscopy and an intramuscular steroid injection to determine if the child has steroid-resistant asthma, using a novel, multidomain approach because the adult definition does not apply to around half the children we see. Finally, we highlight some mechanistic data which have emerged from this protocol such as the absence of T-helper 2 (TH2) cytokines even in eosinophilic severe asthma and the potential role of the innate epithelial cytokine IL-33, novel data on lineage negative innate lymphoid cells, which we can measure in induced sputum, and demonstrating that intraepithelial neutrophils are associated with better, not worse asthma outcomes. Severe paediatric asthma is very different from severe asthma in adults, and approaches must not be uncritically extrapolated from adult disease to children.
引用
- Bush A, Fleming L, Saglani S, et al. Severe asthma in children. Respirology. 2017. PMID: 28543931. doi:10.1111/resp.13085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。